Amir Lahav is a Digital Health Advisor and a leading innovator at the forefront of clinical research. He is inspired by medical innovation, driven by science, and believe in the power of AI-driven solutions to transform clinical trials, discover new treatments, and improve patient experience. Amir has nearly two decades of experience in the biotech and healthcare industries. He currently sits on the Advisory Board of leading HealthTech and DTx startups, and holds several consulting roles with pharma companies, including Head of Strategic R&D and Digital Health Innovation at Mitsubishi Tanabe Pharma, and Chief of Digital Health Strategy at Redenlab. Formerly, Amir served as the Head of Digital Innovation for Rare Diseases at Pfizer, and prior to pharma, was a PI on numerous clinical trials as a Neurology Faculty and Professor of Pediatrics and at Harvard Medical School.